Martina Mariani

Dr. Martina Mariani

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
Ramona IseppiRamona Iseppi
Ramona Iseppi
MMMartina Mariani
Martina Mariani
SBstefania benvenuti
stefania benvenuti
ETEleonora Truzzi
Eleonora Truzzi
Patrizia MessiPatrizia Messi
Patrizia Messi
In the present investigation, the anti-biofilm potential of two essential oils (EOs), Melaleuca alternifolia Chell (Tea-Tree) (TTO) and Eucalyptus globulus Labill. (EEO) was characterized and tested “in vitro” against both mature biofilms and biofilms in the process of formation, produced by strains belonging to three main categories of antibiotic resistant bacteria (ARB): Vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus (MRSA) and broad-spectrum β-lactamase-producing Escherichia coli (ESBL). The study was carried out in 96-well microtiter-plates using EOs alone, in association with each other and in combination with antibiotics against both single and multi-species biofilm. The study demonstrated the ability of TTO and EEO to counteract the ARB strains in sessile form, with promising results in particular against the biofilm in formation. Mature biofilm by ESBL E. coli was the most sensitive in the results from the quantification study of viable cells performed in multi-species biofilms. Lastly, in all tests, carried out using TTO/EEO associations and EOs/antibiotic combinations, the synergistic effect which emerged from the FIC-index has been confirmed, and both the reduction of biofilm in formation, and the removal of mature structure was obtained at very low concentrations, with values from 4 to >512-fold lower than the minimum inhibitory concentration (MIC) of the single compounds.

7 November 2025 in Acta Microbiologica Hellenica
Verified
Journal Article
Open access
PDF file
FCFrancesco Coletta
Francesco Coletta
ASAngela Sinagoga
Angela Sinagoga
MMMartina Mariani
Martina Mariani
GNGiuseppe Napolitano
Giuseppe Napolitano
PRPasquale Rinaldi
Pasquale Rinaldi
RVRomolo Villani
Romolo Villani
Severely burned patients are at high risk of local and systemic infections due to skin barrier loss. Their clinical management is complex and requires coordinated intensive care and infection prevention strategies. Diagnosing infective endocarditis (IE) in this population is particularly difficult due to overlapping symptoms and limited diagnostic specificity. Common pathogens include Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii. We conducted a retrospective cohort study on 543 patients with burns affecting >18% of total body surface area (TBSA), admitted to our Burn Intensive Care Unit (BICU) from 2019 to 2024. The incidence of infective endocarditis was 1.47%, involving aortic (75%), mitral (12.5%), and tricuspid (12.5%) valves. Pathogens identified included S. aureus, Klebsiella pneumoniae, A. baumannii, and P. aeruginosa. This incidence is significantly higher than that in the general population. Mortality reached 50%, with an overall 3-month mortality of 75%. The literature on IE in burn patients is scarce, and the role of antibiotic prophylaxis remains controversial. Infective endocarditis in burn patients, although rare, represents a severe complication with high mortality. Early diagnosis and coordinated multidisciplinary care are essential to improve patient outcomes.

27 December 2024 in Translational Medicine @ UniSa
Verified
Journal Article
Open access
PDF file
MMMartina Mariani
Martina Mariani
RVRomolo Villani
Romolo Villani
ASAnna De Simone
Anna De Simone
SCSimona Cotena
Simona Cotena
RPRossella Pirolli
Rossella Pirolli
RARaffaele Annunziata
Raffaele Annunziata
Introduction: Emergency upper gastrointestinal (GI) endoscopy is often prolonged and complex, performed during high-risk conditions. These procedures can be affected by an increased risk for airway compromise. Scarce literature can be found providing guidance on anesthesiological conduct during upper GI endoscopy in Emergency. Methods: This was a monocentric retrospective study conducted on 96 patients treated in the Emergency Gastroenterology Unit at AORN Cardarelli, between June and October 2023. Key features of moderate and deep sedation procedures were investigated. Results: There was no statistically significant difference in the incidence of complications and respiratory depression between the patients receiving moderate sedation versus those treated with deep sedation. Discussion: Adverse outcomes of sedation and analgesia during endoscopic procedures are rare, even during a deep state of sedation.

10 April 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Ramona IseppiRamona Iseppi
Ramona Iseppi
MMMartina Mariani
Martina Mariani
Carla SabiaCarla Sabia
Carla Sabia
Patrizia MessiPatrizia Messi
Patrizia Messi
Among free-living amoebae (FLA), Acanthamoeba polyphaga is an important causal agent of Acanthamoeba keratitis (AK), a severe and potentially sight-threatening condition. The present study evaluated the “in vitro” efficiency of Melaleuca alternifolia Cheel (tea tree) (tea tree oil—TTO) and Eucalyptus globulus Labill. (Eucalyptus essential oil—EEO) essential oils against an Acanthamoeba strain isolated from human keratitis. The Minimum Inhibitory Concentration (MIC) of the EOs and the Fractional Inhibitory Concentration (FIC) Index were used to evaluate the decrease in viable cells of Acanthamoeba over time and at different concentrations of EOs, used alone or in association. A relevant amoebicidal effect emerged during the first hours of exposure for both compounds, and TTO was the most effective. The TTO/EEO association clearly indicated a synergistic effect in all tests, and at 2 days post-treatment, no viable A. polyphaga cells were observed at all tested concentrations. In conclusion, the potential therapeutic use of EOs represents a promising therapeutic strategy for the treatment of AK.